A peptide derived from SARS-CoV-2 nucleocapsid protein with broad-spectrum anti-coronavirus activity

J Med Virol. 2024 Apr;96(4):e29492. doi: 10.1002/jmv.29492.

Guoguo Ye^{1

2}, Yimin Tang¹, Qin Yang³, Chenhui Zhang^{1

2}, Huiping Shi⁴, Jun Wang¹, Xiao Hu^{1

2}, Xiaofu Wan^{1

5}, Zhixiang Xu¹, Jinhu Liang^{1

2}, Yang Yang^{1

2}, Minghui Yang⁴, Yingxia Liu^{1

2}

¹ Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, Division of Infectious Disease, The Third People's Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
² School of Medicine, Southern University of Science and Technology, Shenzhen, China.
³ College of Life Sciences, Wuhan University, Wuhan, China.
⁴ School of Life Science, Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Advanced Research Institute of Multidisciplinary Sciences, Beijing Institute of Technology, Beijing, China.
⁵ National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, Guangdong Province, China.

No abstract available

Publication types